MetaCap

BrainsWay (BWAY) vs Treace Medical Concepts (TMCI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Treace Medical Concepts (TMCI) has outperformed BrainsWay (BWAY) over the past year, gaining 50.7% versus a gain of 13.9%. Over five years, BWAY leads with a +130.7% price change compared with -75.9% for TMCI. BrainsWay is the larger company by market cap ($341.3 million vs $282.6 million), about 1.2 times the size.

BrainsWay converts more of its revenue into profit, with a net margin of 7.1% versus -27.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BWAY+13.90%TMCI+50.70%
+140%+36%-67%
Nov 21, 20251 yearNov 20, 2026
BWAY+113.60%TMCI-77.97%
+354%+119%-115%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BWAY versus TMCI key metrics
MetricBWAYTMCI
Share price$8.48$4.31
Market cap$341.35M$282.56M
1-day change-2.86%-0.92%
YTD return-10.83%+75.92%
1-year return+13.90%+50.70%
5-year return+130.75%-75.91%
P/E ratio (TTM)35.33—
Forward P/E16.96—
EPS (TTM)$0.24$-0.85
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$41.02M$212.69M
Revenue growth (YoY)+29.04%+1.59%
Net income (latest FY)$2.92M$-59.00M
Gross margin74.56%79.81%
Operating margin3.39%-25.46%
Net margin7.12%-27.74%
52-week high$17.40$5.44
52-week low$7.30$1.17
Distance from 52-week high-51.26%-20.77%
Analyst consensusstrong_buybuy
Avg. price target upside+127.24%+43.16%
Average volume110.35K267.11K
Shares outstanding40.25M65.56M
Employees129450
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • TMCI has outperformed BWAY by 36.8 percentage points over the past year.
  • BrainsWay is more profitable, keeping 7.1 cents of every revenue dollar as net income versus -27.7 cents for Treace Medical Concepts.
  • BrainsWay grew revenue faster in its latest fiscal year (+29.04% vs +1.59%).

About BrainsWay

BWAY stock →

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally.

Health Care · Medical/Dental Instruments · 129 employees

About Treace Medical Concepts

TMCI stock →

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions.

Health Care · Medical/Dental Instruments · 450 employees

BWAY vs TMCI FAQ

Which is bigger, BrainsWay or Treace Medical Concepts?

BrainsWay (BWAY) is larger, with a market capitalization of $341.35M compared with $282.56M for Treace Medical Concepts (TMCI).

Which stock has performed better over the past year, BWAY or TMCI?

TMCI returned +50.70% over the past 12 months, compared with +13.90% for BWAY (price return, excluding dividends). Past performance does not predict future results.

Are BrainsWay and Treace Medical Concepts in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons